These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 16956919)

  • 1. Apoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.
    Mudter J; Neurath MF
    Gut; 2007 Feb; 56(2):293-303. PubMed ID: 16956919
    [No Abstract]   [Full Text] [Related]  

  • 2. New strategies in the management of inflammatory bowel disease.
    Rutgeerts P; Baert F
    Acta Clin Belg; 1999 Oct; 54(5):274-80. PubMed ID: 10555385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell apoptosis and inflammatory bowel disease.
    Peppelenbosch MP; van Deventer SJ
    Gut; 2004 Nov; 53(11):1556-8. PubMed ID: 15479669
    [No Abstract]   [Full Text] [Related]  

  • 4. Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy.
    Ramos JM; García-Sepulcre MF; Masiá M; Brotons A; Grau MC; Gutiérrez F
    Rev Esp Enferm Dig; 2010 Oct; 102(10):614-6. PubMed ID: 21039077
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical therapies for inflammatory bowel disease.
    Stotland BR; Cirigliano MD; Lichtenstein GR
    Hosp Pract (1995); 1998 May; 33(5):141-4, 149-51, 156 passim. PubMed ID: 9606359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory bowel disease.
    Podolsky DK
    N Engl J Med; 2002 Aug; 347(6):417-29. PubMed ID: 12167685
    [No Abstract]   [Full Text] [Related]  

  • 7. The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease.
    Chapman CG; Rubin DT
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):353-65. PubMed ID: 24975527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in inflammatory bowel disease therapy.
    Thomson AB; Williams CN
    Can J Gastroenterol; 1999 Nov; 13(9):775-6. PubMed ID: 10633831
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of inflammatory bowel disease care.
    Sandborn WJ
    Rev Gastroenterol Disord; 2009; 9(3):E69-77. PubMed ID: 19898267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "In vitro" azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's Disease.
    Cossu A; Biancone L; Ascolani M; Pallone F; Boirivant M
    J Crohns Colitis; 2013 Jul; 7(6):441-50. PubMed ID: 22840925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histopathologic diagnosis of the activity of chronic inflammatory bowel disease. Evaluation of the effect of drug treatment. Use of histological scores].
    Geboes K; Desreumaux P; Jouret A; Ectors N; Rutgeerts P; Colombel JF
    Gastroenterol Clin Biol; 1999 Oct; 23(10):1062-73. PubMed ID: 10592879
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel signal transduction pathways: analysis of STAT-3 and Rac-1 signaling in inflammatory bowel disease.
    Atreya R; Atreya I; Neurath MF
    Ann N Y Acad Sci; 2006 Aug; 1072():98-113. PubMed ID: 17057193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunopathogenesis of inflammatory bowel diseases].
    Neurath MF; Schürmann G
    Chirurg; 2000 Jan; 71(1):30-40. PubMed ID: 10662999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis.
    Swidsinski A; Loening-Baucke V; Bengmark S; Lochs H; Dörffel Y
    Inflamm Bowel Dis; 2007 Jan; 13(1):51-6. PubMed ID: 17206639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question.
    Neurath MF; Finotto S; Fuss I; Boirivant M; Galle PR; Strober W
    Trends Immunol; 2001 Jan; 22(1):21-6. PubMed ID: 11286687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug therapy of inflammatory bowel diseases].
    Silvennoinen J; Niemelä S
    Duodecim; 1999; 115(20):2233-8. PubMed ID: 11973927
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
    Ford AC
    Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolving treatment strategies for inflammatory bowel disease.
    Hanauer SB; Dassopoulos T
    Annu Rev Med; 2001; 52():299-318. PubMed ID: 11160781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis, inflammatory bowel disease and carcinogenesis: overview of international and Greek experiences.
    Kountouras J; Kouklakis G; Zavos C; Chatzopoulos D; Moschos J; Molyvas E; Zavos N
    Can J Gastroenterol; 2003 Apr; 17(4):249-58. PubMed ID: 12704469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
    Reinisch W; Stange EF;
    Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.